Why should you invest in VERIGRAFT? Here is the testimonial of Fredrik Wessberg, Chief Executive Officer at CCRM Nordic:
“VERIGRAFT is an outstanding innovator in regenerative medicine, pushing the boundaries of what’s possible in personalized tissue therapies. Their technology has the potential to transform the treatment landscape for patients suffering from chronic vascular diseases. As a collaboration partner, VERIGRAFT is highly professional, forward-thinking, and deeply committed to scientific excellence. We at CCRM Nordic are proud to support their journey and look forward to continued collaboration in advancing next-generation ATMP solutions.”
Learn more about our crowdfunding at https://lnkd.in/dMjTKpST or use the QR code in the picture.